Transforming diagnostic & therapeutic procedures in coronary intervention
Home > Products > R&D
Our project
CVD(Cardiovascular Disease) is the leading cause of death in the world. MPXA supports clinicians with real-time, more accurate analysis of the state of stenosis through state-of-the-art deep learning technology.
Expected Results
More Safety, Efficiency, and Accuracy
Hospital
Boosts procedural efficiency, lowering personnel and treatment time requirement.
Doctors
Significantly reduces radiation exposure and elevates procedural success rate, leading to improved patient outcomes and clinical efficacy.
Patient
Optimizes healthcare resource utilization by reducing treatment costs and shorting recovery time, while minimizing the need for contrast medium and lowering complication risks.
